Edition:
United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,512JPY
23 Jan 2019
Change (% chg)

-- (--)
Prev Close
¥1,512
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,210,215
52-wk High
¥2,061
52-wk Low
¥1,470

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 22.12 March 23 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 4 4 4 4
(3) HOLD 6 7 7 7
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.73 2.64 2.64 2.64

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 1 59,400.00 59,400.00 59,400.00 --
Quarter Ending Mar-19 3 62,032.30 63,841.00 60,956.00 --
Year Ending Mar-19 11 237,230.00 240,332.00 233,700.00 228,357.00
Year Ending Mar-20 11 250,369.00 260,000.00 244,550.00 241,382.00
Earnings (per share)
Quarter Ending Jun-19 1 22.12 22.12 22.12 --
Quarter Ending Mar-19 2 17.99 18.48 17.51 --
Year Ending Mar-19 12 78.39 88.58 68.50 75.76
Year Ending Mar-20 12 84.84 98.30 74.70 84.60
LT Growth Rate (%) 1 3.70 3.70 3.70 10.18

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 57,961.70 57,861.00 100.67 0.17
Quarter Ending Jun-18 58,817.80 56,483.00 2,334.75 3.97
Quarter Ending Mar-18 54,958.00 56,350.00 1,392.00 2.53
Quarter Ending Dec-17 58,288.70 57,818.00 470.67 0.81
Quarter Ending Sep-17 52,350.70 54,825.00 2,474.33 4.73

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 59,400.00 59,400.00 59,400.00 59,400.00 --
Quarter Ending Mar-19 62,032.30 62,032.30 62,026.70 62,026.70 --
Year Ending Mar-19 237,230.00 237,230.00 237,352.00 237,178.00 228,357.00
Year Ending Mar-20 250,369.00 250,369.00 250,874.00 250,762.00 241,382.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-19 0 0 0 0
Quarter Ending Mar-19 0 0 1 0
Year Ending Mar-19 0 0 1 1
Year Ending Mar-20 0 0 0 2
Earnings